UK Research Reveals Striking Misinformation About CBD

October 24, 2019 08:00:05

Cannabis is a divisive plant, and people tend to have differing opinions on it. The plant is mostly known for its two primary cannabinoids, THC delta-9 (tetrahydrocannabinol) and cannabidiol (CBD). THC is the principal psychoactive agent in cannabis, and that’s what gives users the infamous psychotropic high. CBD, on the other hand, affects the body quite differently. Unlike the out of body high THC users experience, CBD is a miracle drug of sorts. Users have reported relief from chronic pain and inflammation, insomnia, anxiety, and a host of other diseases. Despite this, people often lump the two together, and a recent study carried out in the UK found out that a lot of people have trouble differentiating the two compounds.

The project was commissioned by CBD oil manufacturer Dr. Ed, and of the 2000 adults surveyed, more than three-quarters of them were confused about CBD. Although CBD oil is legal in the UK as it does not contain THC, two-thirds of the people believe the product is illegal.  Eight in ten people think that using the non-psychoactive CBD oil has the same physical effect as smoking marijuana, and more than half of the people surveyed said they would judge…


About CBDWire

CBDWire (CBDW) is a specialized information provider focused on (1) reporting CBD-related news and updates, (2) releasing CBDNewsBreaks crafted to keep investors abreast of the latest and greatest in the CBD market, (3) refining and enhancing corporate press releases, (4) delivering end-to-end distribution and social media services to client-partners and (5) constructing effective corporate communication solutions based on the unique requirements of CBD companies. CBDW is exclusively positioned in the burgeoning CBD sector with a proven team of journalists and researchers working to deliver high quality content to an expansive target audience of investors, consumers and industry news outlets. Our dissemination network of over 5,000 downstream distribution points allows us to deliver unparalleled reach, visibility and recognition to companies operating in both cannabidiol and the wider cannabis space. CBDWire (CBDW) is where CBD news, content and information converge.

To receive instant SMS alerts, text CBDWire to 21000 (U.S. Mobile Phones Only)

For more information please visit

Please see full terms of use and disclaimers on the CBDWire website applicable to all content provided by CBDW, wherever published or re-published:

Do you have a questions or are you interested in working with CNW? Ask Our Editor

Denver, Colorado
303.498.7722 Office